Loading...
HomeMy WebLinkAbout09.23.26 Board Correspondence - FW_ Allison Inquiry 08-11 September 2026 Ottawa, Canada Expert testimony Denis Rancourt, PhDFrom:Clerk of the Board To:Jessee, Meegan Cc:Lee, Lewis Subject:Board Correspondence - FW: Allison Inquiry 08-11 September 2026 Ottawa, Canada Expert testimony Denis Rancourt, PhD Date:Wednesday, September 23, 2026 4:55:24 PM Attachments:Rancourt-slides-Allison-Inquiry-2026-09-08-v9-final-zenodo2.pdf image001.png Lewis LeeAdministrative Technician - ConfidentialButte County Administration25 County Center Drive, Suite 200 • Oroville, CA 95965T: 530.552.3326www.buttecounty.ca.gov | lelee@buttecounty.ca.gov From: lance dreiss <lancedreiss@att.net> Sent: Wednesday, September 23, 2026 8:34 AM To: Shared Mailbox Clerk of the Board <pcbs@countyofplumas.com>; Assemblymember.Gallagher@assembly.ca.gov; Senator.Dahle@senate.ca.gov; danpargee@countyofplumas.com; davidhollister@countyofplumas.com; District Attorney <District_Attorney@buttecounty.ca.gov>; Nicolereinert@countyofplumas.com; Kitts, Melissa <mkitts@buttecounty.ca.gov>; Soderstrom, Monica <msoderstrom@buttecounty.ca.gov>; Durfee, Peter <PDurfee@buttecounty.ca.gov>; Ronald Owens <ronald@muzzledtruth.com>; Kimmelshue, Tod <TKimmelshue@buttecounty.ca.gov>; Pickett, Andy <APickett@buttecounty.ca.gov>; Connelly, Bill <BConnelly@buttecounty.ca.gov>; Teeter, Doug <DTeeter@buttecounty.ca.gov>; Beaudoin, Jarett <JBeaudoin@buttecounty.ca.gov>; Julie Threet <julie4butte5@gmail.com>; Waugh, Melanie <mwaugh@buttecounty.ca.gov>; Ritter, Tami <TRitter@buttecounty.ca.gov>; Teri DuBose <Teri.DuBose@mail.house.gov>; Clerk of the Board <clerkoftheboard@buttecounty.ca.gov>; Stephens, Brad J. <BStephens@buttecounty.ca.gov> Subject: Allison Inquiry 08-11 September 2026 Ottawa, Canada Expert testimony Denis Rancourt, PhD .ATTENTION: This message originated from outside Butte County. Please exercise judgment before opening attachments, clicking on links, or replying.. Public Record https://urldefense.com/v3/__https://correlation-canada.org/wp- content/uploads/2026/09/Rancourt-slides-Allison-Inquiry-2026-09-08-v9-final- zenodo2.pdf__;!!KNMwiTCp4spf!FNBPDTYcBIzf7ytFMCc9UJ95CDSm- 9Md3i9PwmQwvS_Z_KhUe2EQ-GRSQpJ7OSxuJ1RYkiAt1PD794t2sLst0AN6Sx7Iog$ diana dreiss 08-11 September 2026 Ottawa, Canada Expert testimony Denis Rancourt, PhD 1 Cite as: Rancourt, D. G. (2026, September 8). Denis G Rancourt expert-witness presentation slides to the Allison Inquiry - Pregnancy, infant, toddler and accelerated cancer excess mortalities. Zenodo. Allison Inquiry, Ottawa, Canada. https://doi.org/10.5281/zenodo.22676709 2 For background and research go to the published reports at: correlation-canada.org ● Start with the 13-May-2026 overview report: “Eight pivotal facts about Covid-period excess mortality” 3 Fact #1: The scale of excess all‑cause mortality during the Covid period was 0.13 % of population per year. (30.9M, 2020-2022) Fact #2: The Covid-period excess mortality was not caused by a spreading respiratory pathogen. Fact #3: Most Covid-period excess mortality in young adults and the youth is not assigned to respiratory conditions (COVID-19). Fact #4: Excess mortality during the Covid period was highly heterogeneous, tied to imposed measures and medical protocols in specific jurisdictions and locations and in specific population groups. Fact #5: The COVID-19 vaccine has harmed and killed many people. Fact #6: Sharp peaks in excess mortality were temporally associated with rapid vaccine and booster rollouts. Fact #7: Vaccination-status-discerned mortality studies show no statistically significant mortality-averting benefit or mortality-causing liability from COVID-19 vaccines. Fact #8: There is a large systematic sex disparity in Covid-period excess mortality from main assigned causes, including (nominally COVID-19) respiratory disease. Eight pivotal facts about Covid-period excess mortality 4 I describe two types of harm detected in excess mortality data having temporal associations to Covid-period events I II Localized to individuals Widespread to populations Vaccine-associated harm General harm Each type of harm can be transient or persistent. The two are not independent from each other. 5 PLAN PART‒I sections (vaccine harm) 1►COVID-19 vaccines injured and killed 2►Pregnant women and their infants died 3►Toddlers and preschoolers died 4►Cancer mortality anomalously increased PART‒II sections (general harm) 5►Canada’s national mortality context 6►Factors correlated to excess mortality 7►Impact of broad Covid-period measures 8►Absence of viral-disease spread mortality 9►Conclusion about causes 6 SOURCES OF DATA All national mortality and cause-of-death data is from official government open source databases. USA: wonder.cdc.gov Canada: statcan.gc.ca 7 PART I I II Localized to individuals Widespread to populations Vaccine-associated harm General harm Each type of harm can be transient or persistent. The two are not independent from each other. 8 PART‒I sections 1►COVID-19 vaccines injured and killed 2►Pregnant women and their infants died 3►Toddlers and preschoolers died 4►Cancer mortality anomalously increased 9 PART‒I sections 1►COVID-19 vaccines injured and killed 2►Pregnant women and their infants died 3►Toddlers and preschoolers died 4►Cancer mortality anomalously increased The COVID-19 vaccines injured and killed people 10 The COVID-19 vaccines injured and killed people, all ages The COVID-19 vaccines injured and killed people Section 1► 11 TYPES OF EVIDENCE: The COVID-19 vaccines injured and killed people ►Detailed autopsy studies (> 50 studies) ►Adverse effect monitoring (VAERS database) (39K deaths) ►Vaccine-induced pathologies (all systems) ►Skin and organ biopsies ►Universal curated collections of peer-reviewed scientific journal articles (> 4.6K studies) ►Secondary analysis of randomized clinical trial data ►Government vaccine injury compensation programs and awards 12 Detailed autopsy studies (> 50 studies) The COVID-19 vaccines injured and killed people Choi et al. (2021): ●“Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings” Edler et al. (2021): ●“Deaths associated with newly launched SARS-CoV-2 vaccination (Comirnaty®)” Schneider et al. (2021): ●“Postmortem investigation of fatalities following vaccination with COVID-19 vaccines” Sessa et al. (2021): ●“Autopsy Findings and Causality Relationship between Death and COVID‑19 Vaccination: A Systematic Review” Gill et al. (2022): ●“Autopsy Histopathologic Cardiac Findings in 2 Adolescents Following the Second COVID-19 Vaccine Dose” Mörz (2022): ●“Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19” Murata et al. (2022): ●“Four cases of cytokine storm after COVID-19 vaccination: Case report” Etc. (> 50 studies in all) 13 Adverse effect monitoring (VAERS database) > 1.6M AEs, 39K deaths, 75K permanent disabilities The COVID-19 vaccines injured and killed people VAERS through 26 June 2026* 1,677,227 AE Reports 39,182 Deaths 222,828 Hospitalizations 158,005 Urgent care 74,835 Permanently disabled 47,700 Severe allergic reaction 22,549 Heart attacks 5,222 Miscarriages *Source: openvaers.com FDA (23 Aug 2021) – Final Letter Of Authorization 14 Universal curated collections of peer-reviewed scientific journal articles The COVID-19 vaccines injured and killed people > 4.6K studies addressing serious side-effects 15 Universal curated collections of peer-reviewed scientific journal articles The COVID-19 vaccines injured and killed people > 4.5K science publications, latest update 16 PART‒I sections 1►COVID-19 vaccines injured and killed 2►Pregnant women and their infants died 3►Toddlers and preschoolers died 4►Cancer mortality anomalously increased Pregnant women and infants died 17 COVID-19 vaccinated pregnant women and their infants died Pregnant women and infants died Section 2► 18 Pregnant women and infants died Early on, several dedicated researchers sounded the alarm 19 TYPE OF EVIDENCE PRESENTED Temporal associations between: ►vaccination campaigns ►excess all-cause (age 0) mortality ►excess cause-specific mortality Pregnant women and infants died We don’t know the vaccination status for the individuals but we know the directives, practices, and rollouts. 20 USA: pregnancy-related deaths (by week, per LB) accompanying COVID-19 vaccine rollouts, high vs low-poverty states Pregnant women and infants died 500 excess pregnancy-related deaths in the USA, 2021-2022 CDC 2021-08-11 ―advisory that all pregnant women should be vaccinated for COVID-19 1 2 1 = “vaccine equity” campaign 2 = additional dose 1 and boosters WHO CDC 21 Pregnant women and infants died Definition of poor and rich-status states of the USA 7-20% population live in poverty by state (2019): 12% threshold NOTE: Poverty % population stats are essentially the same in Canada. 22 USA: “maternal deaths” (by month, 12-month-ending sums) after the August 2021 CDC directive to vaccinate pregnant women Pregnant women and infants died 500 excess pregnancy-related deaths in the USA, 2021-2022 “Maternal death” ICD-10 codes: A34, O00-O95, O98-O99 (≤ 42 days) WHO vax CDC CDC + 9 months 2021-08-11 23 USA: pregnancy-related deaths (by month) accompanying COVID-19 vaccine rollouts Pregnant women and infants died 500 excess pregnancy deaths in the USA, 2021-2022 WHO CDC CDC + 9 months 1 2 1 = “vaccine equity” campaign 2 = additional dose 1 and boosters 2021-08-11 2022-05-11 24 USA: associated infant deaths (by month, each sex), 9 months later Pregnant women and infants died 2K excess P00-P96 infant deaths, 2022-2024 WHO2021-08-11 +9m 25 USA: infant deaths (by year, by LB) after COVID-19 vaccine rollouts to pregnant women, 9 months later Pregnant women and infants died 4K total excess infant deaths in the USA, 2022-2024 Infant deaths ACM, age 0 ICD-10: P00-P96 (age 0) → 9 months later... 2 years into declared pandemic not 2020, not 2021 → 2022, 2023, 2024 WHO 26 Pregnant women and infants died Canada: evidence for assaults causing death in child-bearing-age women, during the Covid period, ages 15-44 (not COVID-19) 4K excess all-cause deaths, females, ages 15-44, 2021-2024 (includes unintentional substance overdose deaths) WHO VS ~300 COVID-19 deaths, more than X10 less, females, ages 15-44, 2021-2024 4K (all) vs 300 (cv19) excess deaths, 2021-2024 Females, ages 15-44 27 Pregnant women and infants died Canada: National Advisory Committee on Immunization (NACI) recommendations to vaccinate pregnant women *Source: BC Centre for Disease Control 2021-05-28 All in the absence of any clinical trial on pregnant women 28 Pregnant women and infants died Canada: pregnancy-related deaths (by year, per LB) after COVID-19 vaccine approvals 10 excess pregnancy-related deaths in Canada, 2022-2024 WHO NACI NACI 2021-05-28 ―recommendation that all pregnant women should be vaccinated for COVID-19 Surge in LB ‒post travel restrictions 29 Pregnant women and infants died Canada: infant death rate (by year) age < 1 200 excess infant deaths in Canada, 2022-2024 (corresp.: 6 or 7 in Ottawa) WHO NACI + 9m ACM rate, age < 1 → 9 months later... 2 years into declared pandemic not 2020, not 2021 → 2022, 2023, 2024 2022-02-28 30 Pregnant women and infants died Canada: induced abortions reported by year 27K excess abortions in Canada, 2022-2024 WHO NACI INDUCED ABORTIONS to infant population, ratio (%) Fear of fetal defects? Detected fetal defects? 2021-05-28 31 PART‒I sections 1►COVID-19 vaccines injured and killed 2►Pregnant women and their infants died 3►Toddlers and preschoolers died 4►Cancer mortality anomalously increased Toddlers and preschoolers died 32 Toddlers and preschoolers died, in temporal association with approvals of COVID-19 vaccines to ages > 6 m to 12 y Toddlers and preschoolers died Section 3► 33 Toddlers and preschoolers died USA: toddler+ death rate (by year) accompanying FDA COVID-19 vaccine approvals to 6m―4y on 2022-06-17 and earlier severe financial support cuts (2021-June) 2.1K excess deaths, ages 1-4, 2021-2024, USA (Not COVID-19) WHO FDA/CDC 2022-06-17 34 Canada (Quebec data): Health Canada approval dates and rollouts (by dose) of COVID-19 vaccines to toddlers+ [left] 6 months ― 5 years (2022-07-14) (Moderna) [right] 5 years ― 11 years (2021-11-19) (Pfizer) Also: 6 years ― 11 years (2022-03-17) (Moderna) COVID-19 vaccine rollouts to ages 6 months ― 4 years QC COVID-19 vaccine rollouts to ages 5 years ― 11 years QC 2022-07-14 2021-11-19 Toddlers and preschoolers died 6 months ― 4 years 5 years ― 11 years 35 Toddlers and preschoolers died Canada: toddler+ deaths (by year) accompanying Health Canada COVID-19 vaccine approvals: late-2021 and 2022 and financial support cuts (late-2020 ― early-2022) Excess toddler+ deaths in Canada, 2022-2024 Ages 1-4: 130 Ages 5-9: 140 Ages 10-14: 140 Total ages 1-14: 410 (Surge in 2022, not COVID-19) COVID-19-assigned deaths X10 less 36 PART‒I sections 1►COVID-19 vaccines injured and killed 2►Pregnant women and their infants died 3►Toddlers and preschoolers died 4►Cancer mortality anomalously increased Increased cancer mortality after COVID-19 vaccine rollouts 37 Increased cancer mortality after COVID-19 vaccine rollouts, overall and in young people Increased cancer mortality after COVID-19 vaccine rollouts Section 4► 38 Increased cancer mortality after COVID-19 vaccine rollouts There is an established body of scientific studies on a surge of “hyperprogressive disease [cancer]” (HPD) temporally associated with vastly increased use of immune- therapy drugs since approx. 2015 to present. Champiat et al. (2017): ●Hyperprogressive Disease Is a New Pattern of Progression in Cancer Patients Treated by Anti-PD-1/PD-L1. Clin Cancer Res 15 April 2017; 23 (8): 1920–1928. Champiat et al. (2018): ●Hyperprogressive disease: recognizing a novel pattern to improve patient management. Nat Rev Clin Oncol 15, 748–762. Liu et al. (2026): ●Reported drug spectrum and disproportionality signals for malignant neoplasm progression in FAERS: a real-world pharmacovigilance study. Front. Pharmacol. 17:1814403. Shin et al. (2023): ●Spending, Utilization, and Price Trends for Immune Checkpoint Inhibitors in US Medicaid Programs: An Empirical Analysis from 2011 to 2021. Clin Drug Investig 43, 289–298. Etc. (approx. 300 articles in all) Approx. 300 articles with “HPD” in the title, to date, starting in 2017 39 Increased cancer mortality after COVID-19 vaccine rollouts Clinicians are reporting “turbo cancers” (increased incidence and high severity in young patients) Scientific articles are now being published J Indep Med 2025 Vol. 1 No. 3, pp. 185-194 40 TYPE OF EVIDENCE PRESENTED ►Temporal trends of excess cancer mortality ►(associated with) COVID-19 vaccine rollouts Increased cancer mortality after COVID-19 vaccine rollouts We don’t know the vaccination status for the individuals but we detect sudden temporal changes. 41 CANCER TYPE, AGE GROUP (EXCESS DEATHS) USA Increased cancer mortality after COVID-19 vaccine rollouts ●All cancers, ages 5-24 (960 excess deaths 4y) ●All cancers, ages 25-44 (2900 excess deaths 4y) ●All cancers, ages 5-44 (4400 excess deaths 4.4y) ●Spec. long bone limb cancer, ages 5-24 (70 excess deaths 4y) ●Spec. leukemias, ages 5-24 (360 excess deaths 4y) ●Spec. (primary) multiple site cancer, ages 25-44 (240 excess deaths 5y) ●Spec. (primary) multiple site cancer, ages 75+ (1500 excess deaths 4y) ALSO: 15-44 ages = Respiratory (C30-C39), Oral (C00-C14), Digestive (C15-C26). Examples from our analyses (some graphs below). 42 USA: all cancers by month, ages 5-44 (1999-2025) Increased cancer mortality after COVID-19 vaccine rollouts ALL CANCERS ICD-10: C00-C97 4400 excess deaths Ages 5-44 During 4.4 years WHO ―Financial Support Cuts―Surge in “Vaccine Equity” Rollouts → NOTE: Downslope from post-war baby boom 2020-03-11 2021-06 4.4K excess cancer deaths in the USA, ages 5-44 43 USA: all cancers by year, ages 5-24 (1999-2025) Increased cancer mortality after COVID-19 vaccine rollouts ALL CANCERS 960 excess deaths Ages 5-24 During 4 years WHO 960 excess cancer deaths in the USA, ages 5-24 44 USA: deaths from long bone limb cancer by year, ages 5-24 (1999-2025) Increased cancer mortality after COVID-19 vaccine rollouts LONG BONE LIMB CANCER ICD-10: C40.2 (Rare and only in youth) 70 excess deaths Ages 5-24 During 4 years WHO 70 excess LBL-cancer deaths in the USA, ages 5-24 45 USA: deaths from (primary) multiple site cancer by year, ages 25-44 (1999-2025) Increased cancer mortality after COVID-19 vaccine rollouts (PRIMARY) MULTIPLE SITE CANCER ICD-10: C97 240 excess deaths (100 male, 140 female) Ages 25-44 During 4 years WHO 240 excess (P)MS-cancer deaths in the USA, ages 25-44 46 USA: deaths from (primary) multiple site cancer by year, ages 75+ (1999-2025) Increased cancer mortality after COVID-19 vaccine rollouts (PRIMARY) MULTIPLE SITE CANCER ICD-10: C97 1500 excess deaths (900 male, 600 female) Ages 75+ During 4 years WHO 1.5K excess (P)MS-cancer deaths in the USA, ages 75+ 47 PART II I II Localized to individuals Widespread to populations Vaccine-associated harm General harm Each type of harm can be transient or persistent. The two are not independent from each other. 48 PART‒II sections 5►Canada’s national mortality context 6►Factors correlated to excess mortality 7►Impact of broad Covid-period measures 8►Absence of viral-disease spread mortality 9►Conclusion about causes 49 PART‒II sections 5►Canada’s national mortality context 6►Factors correlated to excess mortality 7►Impact of broad Covid-period measures 8►Absence of viral-disease spread mortality 9►Conclusion about causes CANADA’S NATIONAL MORTALITY CONTEXT 50 Section 5► 51 Canada: mortality by main cause, ages 15-44 Suicides COVID-19 Car Accidents Opioids – Fentanyl (ICD-10: X40―X49) 52 Canada: mortality (by year) by main cause, ages 45-74 Cardiovascular Diseases (ICD-10: I00―I78) COVID-19 All Cancers 53 Canada: mortality (by year) by main cause, ages 75+ Dementia Chronic Respiratory Pneumonia COVID-19 All Cancers Cardiovascular Diseases (ICD-10: I00―I78) 54 PART‒II sections 5►Canada’s national mortality context 6►Factors correlated to excess mortality 7►Impact of broad Covid-period measures 8►Absence of viral-disease spread mortality 9►Conclusion about causes FACTORS CORRELATED TO EXCESS MORTALITY IN THE COVID PERIOD 55 Section 6► 56 Canada: We analysed >80 province-specific SOCIOECONOMIC FACTORS: poverty, disability, age structure, obesity, stress, institutional characteristics, economic factors, family structure, etc. ►Correlations by age and by time... 57 Correlation coefficients (raw, weighted, confidence intervals) P-score & 2019 GDP all-sectors (by half-year, by age, by sex) (Canada) 58 P-score (Covid period), all-ages GDP all sectors (M$) per capita by province (Canada) Q: Why? A: Economic sutdown GDP all sectors (M$) per capita 59 Opioid deaths vs GDP real estate (both per capita, 2019, by province, Canada) poor while living near the wealthy 60 P-score (2020-H1): all-ages, age 85+ % Large Hospitals by province (Canada) % Large Hospitals 61 Montréal-Laval Lanaudiѐre-Laurentides- Montérégie all other QC (Canada) 62 PART‒II sections 5►Canada’s national mortality context 6►Factors correlated to excess mortality 7►Impact of broad Covid-period measures 8►Absence of viral-disease spread mortality 9►Conclusion about causes IMPACT OF BROAD COVID-PERIOD MEASURES 63 Section 7► 64 xACM/w, age 85+ and intensity of protection of elderly people “Focussed Protection” → Peak and large dry tinder effect WHO 65 P-score/w, all ages and significant financial assistance programs 1 2 3 Loss of financial assistance x2 WHO 66 Numbers living in poverty (NACP, 2025) 67 PART‒II sections 5►Canada’s national mortality context 6►Factors correlated to excess mortality 7►Impact of broad Covid-period measures 8►Absence of viral-disease spread mortality 9►Conclusion about causes ABSENCE OF VIRAL-DISEASE SPREAD CAUSING EXCESS MORTALITY 68 Section 8► GEOTEMPORAL: PROOF THAT THERE WAS NO VIRAL DISEASE SPREAD CAUSING DEATH 69 Hickey, Rancourt, Linard (2025) “Constraints from geotemporal evolution of all-cause mortality on the hypothesis of disease spread during Covid" – correlation-canada.org – hal.science/hal-05123573/ 70 THERE WAS NO VIRAL RESPIRATORY DISEASE SPREAD CAUSING EXCESS MORTALITY Geostatic time evolution, not geotemporal Impenetrable borders despite large continued traffic Virtually nothing prior to WHO declaring a pandemic (2020-03-11) Synchronicity of hotspots across continents Unprecedented mid-summer mortality peaks, in each hemisphere Milan vs Rome NYC vs Los Angeles / San Francisco 71 Hickey et al. (2025) "Constraints from geotemporal evolution of all-cause mortality on the hypothesis of disease spread during Covid" USA East & West coasts, with equally busy international airports 72 The empirical mortality data is incompatible with state-of-the-art theoretical calculations (here, Davis et al., 2021) of global contagion spread during Covid: re. Milan/Rome and East/West USA Hickey et al. (2025) "Constraints from geotemporal evolution of all-cause mortality on the hypothesis of disease spread during Covid" 73 PART‒II sections 5►Canada’s national mortality context 6►Factors correlated to excess mortality 7►Impact of broad Covid-period measures 8►Absence of viral-disease spread mortality 9►Conclusion about causes CONCLUSION ABOUT CAUSES 74 Section 9► 75 Government assaults: economic deprivation (loss of employment), fear propaganda, mandates, measures, public-health responses, and medical assaults. Medical assaults (largescale and repeated): testing, diagnostic bias, imposed facial masking, confinement, isolation, denial of appropriate treatment, mechanical ventilation, sedation, experimental and improper treatments, and vaccination. → Assaults caused injury and death during the Covid period 76 Vaccination is the only measure that involved repeatedly injecting the bodies of all residents ― including the sick, elderly, infants, toddlers, preschoolers and pregnant women (in any gestation period) ― with a known cytotoxic substance (cationic lipids) in a highly dispersive carrier format (lipid nanoparticles). COVID-19 mRNA VACCINATION Cationic lipids are cytotoxic, especially as bio-distributed nanoparticles, irrespective of the cargo. 77 Brimacombe, CA et al. (2025) "Rational design of lipid nanoparticles for enabling gene therapies", Molecular Therapy Methods & Clinical Development. (review) “The fundamental limitation is toxicity. There are no permanently positively charged bilayer forming lipids in nature. Positively charged lipid molecules can combine with the negatively charged lipids found in biological membranes to form non-bilayer structures that disrupt membranes(47) resulting in cytotoxicity(104) and immune activation(105) (activation of complement and coagulation pathways as well as cytokine stimulation(104,106)). This results in rapid clearance by the RES system, inflammation, and other side effects such as thrombosis,(107) lymphopenia, hepatic necrosis, and an overactive innate immune response.(108,109,110)” The manufacturers do not use an “adjuvant”. 78 CONCLUSION History will record that the Covid period was in-effect a massive and unnecessary multi-faceted assault against people, exploiting fear and causing harm, injury and death, especially in the most vulnerable. All governments under USA hegemony and media influence cooperated or imitated. Canada was no exception. The vaccines are toxic and caused many deaths and injuries, in plain sight of robust national mortality statistics. Science can never prove causality but institutional capture and discipline can always minimize and invalidate screaming safety signals and personal hardship. 79 I thank scientific collaborators: Marine Baudin, PhD Joseph Hickey, PhD Jérémie Mercier, PhD And scientists at D4CE for a critical review of a version of the presentation. 80 END OF THE PRESENTATION.